SAN FRANCISCO, June 23, 2025 /PRNewswire/ -- Stelo, an enterprise software company, has filed suit in Federal District Court for the Central District of California against San Diego-based Dexcom, Inc.
Our editors tested two popular glucose monitors to determine which is the best for improving diet, sleep and exercise habits.
The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results